(Q43317289)

19 November 2017

The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling (English)

1 reference

19 November 2017

0 references

irritable bowel syndrome

1 reference

Yingcong Yu

1

1 reference

19 November 2017

Shujuan Wu

2

1 reference

19 November 2017

Jianxin Li

3

1 reference

19 November 2017

Renye Wang

4

1 reference

19 November 2017

Xupei Xie

5

1 reference

19 November 2017

Xuefeng Yu

6

1 reference

19 November 2017

Jianchun Pan

7

1 reference

19 November 2017

Ying Xu

8

1 reference

19 November 2017

Liang Zheng

9

1 reference

19 November 2017

8 May 2014

1 reference

19 November 2017

Metabolic Brain Disease

1 reference

19 November 2017

30

1 reference

19 November 2017

1

1 reference

19 November 2017

47-55

1 reference

https://scigraph.springernature.com/pub.10.1007/s11011-014-9554-z

19 November 2017

0 references

cites work

A randomized controlled trial of imipramine in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Visceral perception: inflammatory and non-inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Antidepressants for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

The serotonin signaling system: from basic understanding to drug development for functional GI disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Curcumin therapy in inflammatory bowel disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Study of expression patterns and levels of neurotrophins and neurotrophin receptors in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Differential changes in brain-derived neurotrophic factor and extracellular signal-regulated kinase in rat primary afferent pathways with colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Effect of electroacupuncture on visceral hyperalgesia, serotonin and fos expression in an animal model of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

The effects of curcumin on depressive-like behaviors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Changes in brain G proteins and colonic sympathetic neural signaling in chronic-acute combined stress rat model of irritable bowel syndrome (IBS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9554-Z

Irritable bowel syndrome, anxiety, and depression: what are the links?

21 January 2018

1 reference

12 December 2020

“Behavioural despair” in rats and mice: Strain differences and the effects of imipramine

1 reference

12 December 2020

STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis

1 reference

12 December 2020

Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials.

1 reference

12 December 2020

Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents

1 reference

12 December 2020

Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats.

1 reference

12 December 2020

Cold-restraint stress increases rat fecal pellet output and colonic transit

1 reference

12 December 2020

A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development

1 reference

12 December 2020

Behavioral despair in mice: a primary screening test for antidepressants

1 reference

12 December 2020

Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells.

1 reference

12 December 2020

10.1007/S11011-014-9554-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

19 November 2017

0 references

1 reference